Zdrowie i gospodarka · 03/11/2017
FDA Clears REVEX Nalmefene Hydrochloride Injection for Approval
The US Food and Drug Administration has determined that REVEX, a nalmefene hydrochloride injection, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.